Cargando…

Casting a Wider NET: Pancreatic Exocrine Insufficiency Induced by Somatostatin Analogues among Patients with Neuroendocrine Tumours?

SIMPLE SUMMARY: Somatostatin analogues (SSA) are used to treat patients with unresectable neuroendocrine tumours (NET). An underrecognized side-effect of SSAs is pancreatic exocrine insufficiency (PEI), where the pancreas is unable to maintain the normal digestion of food. Whilst the few papers that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hall, Lewis A., Powell-Brett, Sarah, Thompson, Oscar, Smith, Daniel, Bradley, Elizabeth, Smith, Stacey, Vickrage, Suzanne, Kemp-Blake, Joanne, Roberts, Keith J., Shah, Tahir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093494/ https://www.ncbi.nlm.nih.gov/pubmed/37046594 http://dx.doi.org/10.3390/cancers15071933

Ejemplares similares

Casting a wider net: Immunosurveillance by nonclassical MHC molecules
por: D’Souza, M. Patricia, et al.
Publicado: (2019)

Casting a Wider Net: The Quest for Better Guidance on Seafood Consumption
por: Betts, Kellyn S.
Publicado: (2012)

Immune Cell Profiling and Risk Stratification: Cast a Wider Net
por: Hammond, M. Elizabeth H.
Publicado: (2020)

Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors
por: Ambrosini, Valentina, et al.
Publicado: (2022)

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future
por: Stueven, Anna Kathrin, et al.
Publicado: (2019)

Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors
por: Watanabe, Hirofumi, et al.
Publicado: (2022)

Pancreatic exocrine insufficiency after pancreaticoduodenectomy: Current evidence and management
por: Pathanki, Adithya M, et al.
Publicado: (2020)

Casting a Wider Net: Engaging Community Health Worker Clients and Their Families in Cancer Prevention
por: Roman, Lee Anne, et al.
Publicado: (2016)

Pulmonary neuroendocrine tumours and somatostatin receptor status: an assessment of unlicensed use of somatostatin analogues in the clinical practice
por: Kiesewetter, B., et al.
Publicado: (2022)

Efficacy and Safety of Everolimus plus Somatostatin Analogues in Patients with Neuroendocrine Tumors
por: Ge, Wenhao, et al.
Publicado: (2018)

Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells
por: Krug, Sebastian, et al.
Publicado: (2019)

Pancreatic Exocrine Insufficiency and the Gut Microbiome in Pancreatic Cancer: A Target for Future Diagnostic Tests and Therapies?
por: Halle-Smith, James M., et al.
Publicado: (2023)

Challenges in the management of pancreatic exocrine insufficiency
por: Shandro, Benjamin Myles, et al.
Publicado: (2018)

Pancreatic Exocrine Insufficiency in Pancreatic Cancer
por: Vujasinovic, Miroslav, et al.
Publicado: (2017)

State of the Art in Exocrine Pancreatic Insufficiency
por: Diéguez-Castillo, Carmelo, et al.
Publicado: (2020)

Nivolumab-Induced Exocrine Pancreatic Insufficiency
por: Sweep, Boudewijn, et al.
Publicado: (2021)

Congenital etiologies of exocrine pancreatic insufficiency
por: Scheers, Isabelle, et al.
Publicado: (2022)

Nutrition in children with exocrine pancreatic insufficiency
por: Zheng, Yuhua, et al.
Publicado: (2023)

Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives
por: Appetecchia, Marialuisa, et al.
Publicado: (2010)

The Somatostatin Analogue Octreotide Inhibits Growth of Small Intestine Neuroendocrine Tumour Cells
por: Li, Su-Chen, et al.
Publicado: (2012)

Long-Acting Somatostatin Analogue Safety Monitoring Protocol for Outpatients With Neuroendocrine Tumors
por: Gabrielsen, Jordan, et al.
Publicado: (2019)

Correction: Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells
por: Krug, Sebastian, et al.
Publicado: (2020)

Treatment with somatostatin analogues and PRRT in metastatic middle ear adenoma with neuroendocrine features
por: Lima Ferreira, Joana, et al.
Publicado: (2021)

Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis
por: Rustgi, Sheila D., et al.
Publicado: (2021)

Chronic Treatment with Somatostatin Analogues in Recurrent Type 1 Gastric Neuroendocrine Tumors
por: Sebastian-Valles, Fernando, et al.
Publicado: (2023)

Casting a Wider Net: Differentiating between Inner Nuclear Envelope and Outer Nuclear Envelope Transmembrane Proteins
por: Tingey, Mark, et al.
Publicado: (2019)

Is there a clinical usefulness for radiolabeled somatostatin analogues beyond the consolidated role in NETs?
por: Cuccurullo, Vincenzo, et al.
Publicado: (2017)

Patient And Nurse Experience Of Using Somatostatin Analogues To Treat Gastroenteropancreatic Neuroendocrine Tumors: Results Of The Somatostatin Treatment Experience Trial (STREET)
por: Ström, Torbjörn, et al.
Publicado: (2019)

Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [(18)F]SiTATE
por: Eschbach, Ralf S., et al.
Publicado: (2023)

Radiolabeled Somatostatin Analogues Therapy in Advanced Neuroendocrine Tumors: A Single Centre Experience
por: Filice, A., et al.
Publicado: (2012)

Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues
por: Saksis, Rihards, et al.
Publicado: (2023)

Pancreatic Exocrine Insufficiency after Bariatric Surgery
por: Vujasinovic, Miroslav, et al.
Publicado: (2017)

Less common etiologies of exocrine pancreatic insufficiency
por: Singh, Vikesh K, et al.
Publicado: (2017)

Exocrine pancreatic insufficiency: prevalence, diagnosis, and management
por: Capurso, Gabriele, et al.
Publicado: (2019)

Update on the diagnosis and management of exocrine pancreatic insufficiency
por: Perbtani, Yaseen, et al.
Publicado: (2019)

Ultrasonographic Findings of Exocrine Pancreatic Insufficiency in Dogs
por: Pelligra, Tina, et al.
Publicado: (2022)

Optimizing management of patients with pancreatic exocrine insufficiency
por: Arvanitakis, Marianna, et al.
Publicado: (2023)

Exocrine Pancreatic Insufficiency in Children – Challenges in Management
por: Sankararaman, Senthilkumar, et al.
Publicado: (2023)

SAT-LB24 Association of Expression of Somatostatin Receptor 2 Subtype in Non-Pituitary Neuroendocrine Tumors With Response to Treatment With Somatostatin Analogues
por: Siddiqui, Abdullah, et al.
Publicado: (2020)

Practical guide to exocrine pancreatic insufficiency – Breaking the myths
por: Struyvenberg, Maarten R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_51ehd1j990iv8lcmttotpkdas1